Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > In hind sight.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(117)
•••
Comment by gojotv!on Apr 02, 2021 3:50am
223 Views
Post# 32931274

RE:In hind sight.

RE:In hind sight.If you have no confidence going forward, and you're a long-term holder, selling on Monday would be the best thing for you.
You'll still make a little money, and there will be plenty of bidders who've had the whole weekend to look at this stock lining up to buy.
Buh-bye! Gap up Monday! GLTA!

StockscoutX wrote: The regular bashers on this board were right on the money after all with most of their posts after todays CC fiasco! Those still cheering for StageZero are like holding so tight tan eel that it's slowly slipping out of their hands.

CEO of StageZero reminds me of stocks in the past that have failed with great products to offer. CEOs that held so tightly to their creation have totally ignored that it's shareholder cash which made it also possible. Moreover, those types of CEOs most of the time take decisions that are not in shareholders best interests.

I am starting to come to the conclusion that we are most likely in the same situation and it's not looking good going forward.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities